Biotech entity
All 2 tracked stories fall under one category: gene-therapy. REGENXBIO Inc. is most often covered alongside Bank of America, which appears in 1 of these 2 stories. Across a 120-day span, the pace is roughly 0.1 stories per week. Their average consequence score of 5 runs below the beat's 6.2 for that window.
Last mentioned: Jul 6, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 2 tracked stories fall under one category: gene-therapy. REGENXBIO Inc. is most often covered alongside Bank of America, which appears in 1 of these 2 stories. Across a 120-day span, the pace is roughly 0.1 stories per week. Their average consequence score of 5 runs below the beat's 6.2 for that window. They are better corroborated than the beat average, carrying 4 original sources each against 3.5 for the same window. This profile follows 2 Biotech stories mentioning REGENXBIO Inc. across the period from March 9, 2026 to July 6, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 317 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering REGENXBIO Inc.. Shared-story counts are live from our verified record — not editorial picks.
REGENXBIO Chief Medical Officer Steve Pakola offloaded 56,333 shares for $688,756 following a disastrous Q1 miss, but analysts maintain price targets implying up to 99% upside. The insider sales add tension to a gene therapy story already defined by high risk and potential reward.
Source: Zolmax · Markets Daily
REGENXBIO reported a wider-than-expected Q4 2025 loss of $1.30 per share, missing analyst estimates of $1.01. The results reflect a broader trend of financial pressure on high-growth biotech and life science firms as they navigate late-stage clinical and commercial transitions.
REGENXBIO Inc. is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
